Obesity, plasma lipids and polymorphonuclear (PMN) granulocyte functions

Area of Science:

• Immunology
• Metabolic Disorders
• Cellular Biology

Background:

• Obesity is a complex metabolic disorder associated with increased inflammation.
• Polymorphonuclear (PMN) granulocytes play a crucial role in innate immunity.
• Understanding immune function in obesity is vital for managing associated health risks.

Purpose of the Study:

• To investigate polymorphonuclear (PMN) granulocyte functions in obese individuals compared to normal-weight controls.
• To examine the relationship between PMN function, plasma lipid profiles, and body weight parameters.

Main Methods:

• Comparison of PMN granulocyte functions (bactericidal capacity, adherence, chemotaxis, opsonic capacity) between 20 obese subjects and 20 normal-weight controls.
• Analysis of plasma lipid levels, including triglycerides, free fatty acids, cholesterol, and phospholipids.
• Correlation analysis between PMN function parameters, plasma lipids, body weight, and Broca's index.

Main Results:

• Obese subjects exhibited significantly decreased PMN bactericidal capacity and increased PMN adherence.
• No significant differences were observed in PMN chemotaxis or plasma opsonic capacity between groups.
• Obese individuals had higher plasma triglycerides and free fatty acids, but similar cholesterol and phospholipids compared to controls.
• Changes in PMN function did not significantly correlate with plasma lipid levels or degree of overweight.

Conclusions:

• Obesity is associated with specific alterations in PMN granulocyte function, notably reduced bactericidal capacity and increased adherence.
• These observed changes in granulocyte function in obesity are independent of plasma lipid levels and the degree of overweight.
• Further research is warranted to elucidate the mechanisms underlying these immune dysfunctions in obesity.